Liver histology as predictor of outcome in patients with acute liver failure

Transplant International

Volumn 25, Issue 6, 2012, Pages 658-662

  Singhal, Ashish ^a   Vadlamudi, Saraschand ^a   Stokes, Kenneth ^b   Cassidy, Francis P ^b   Corn, Ayumi ^b   Shrago, Stan S ^b   Wright, Harlan I ^a   Kohli, Vivek ^a  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b INTEGRIS BAPTIST MEDICAL CENTER   (United States)

Author keywords

acute; biopsy; failure; fulminant; histology; liver; transjugular; transplantation

Indexed keywords

PARACETAMOL; SULFANILAMIDE DERIVATIVE;

ACETAMINOPHEN INDUCED DISEASE; ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AUTOIMMUNE LIVER DISEASE; CHILD; CONFERENCE PAPER; DIAGNOSTIC TEST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG INDUCED DISEASE; ERYTHEMA INFECTIOSUM; EXPLANT; FEMALE; GIANT CELL HEPATITIS; HEMANGIOENDOTHELIOSARCOMA; HEPATITIS; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LIVER BIOPSY; LIVER HISTOLOGY; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TRANSJUGULAR LIVER BIOPSY; TUMOR DIAGNOSIS; WILSON DISEASE;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOCYTES; HUMANS; INFANT; LIVER; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84861188097     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01470.x     Document Type: Conference Paper

References (22)

1. O'Grady JG, Schlam S, Williams R,. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273.
2. Hoofnagle JH, Carithers RL, Sapiro C, Ascher N,. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21: 240.
3. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centres in the United States. Ann Intern Med 2002; 137: 947.
4. Lee WM,. Acute liver failure in the United States. Semin Liver Dis 2003; 23: 217.
5. O'Grady JG, Alexander GJM, Hayllar KM, Williams R,. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439.
6. Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB,. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998; 43: 1311.
7. Akdóan M, El-Sahwi K, Ahmed U, et al. Experience with liver dialysis in acetaminophen induced fulminant hepatic failure: a preliminary report. Turk J Gastroenterol 2003; 14: 164.
8. Kjaergard LL, Liu J, Adils-Neilsen B, Gluud C,. Artificial and bioartificial liver support systems for acute and acute-on-chronic liver failure. JAMA 2003; 289: 217.
9. Horney JT, Galambos JT,. The liver during and after fulminant hepatitis. Gastroenterology 1977; 73: 639.
10. Karvountzis GG, Redeker AG, Peters R,. Long-term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterology 1974; 67: 870.
11. Ware AJ, Eigenbrodt EG, Combes B,. Prognostic significance of subacute hepatic necrosis in acute hepatitis. Gastroenterology 1975; 68: 519.
12. Rakela J, Lange SM, Ludwig J, Baldus WP,. Fulminant hepatitis: Mayo clinic experience with 34 cases. Mayo Clin Proc 1985; 60: 289.
13. Sokol FLJ, Francis PD, Gold SH, Ford DM, Lum GM, Ambruso DR,. Orthotopic liver transplantation for fulminant Wilson's disease. J Pediatr 1985; 107: 549.
14. Kalambokis G, Manousou P, Vibhakorn S, et al. Transjugular liver biopsy-indications, adequacy, quality of specimens, and complications-a systematic review. J Hepatol 2007; 47: 284.
15. Cholongitas E, Quaglia A, Samonakis D, et al. Transjugular liver biopsy: how good is for accurate histological interpretation? Gut 2006; 55: 1789.
16. Mammen T, Keshava SN, Eapen CE, et al. Transjugular liver biopsy: a retrospective analysis of 601 cases. J Vasc Interv Radiol 2008; 19: 351.
17. Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993; 18: 1370.
18. Miraglia R, Luca A, Gruttadauria S, et al. Contribution of transjugular liver biopsy in patients with the clinical presentation of acute liver failure. Cardiovasc Intervent Radiol 2006; 29: 1008.
19. Macedo G, Maia JC, Carneiro F, et al. Contribution of transjugular liver biopsy in fulminant hepatic failure. Transplant Proc 2000; 32: 2643.
20. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT,. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716.
21. Sacks D, McClenny TE, Cardella JF, Lewis CA,. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14: S199.
22. Hanau C, Munoz SJ, Rubin R,. Histopathological heterogeneity in fulminant hepatic failure. Hepatology 1995; 21: 345.